REGENERON PHARMACEUTICALS, INC.: FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

EISAI INC.: Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)